These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 16640737)
1. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials. Jennens RR; Giles GG; Fox RM Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737 [TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872 [TBL] [Abstract][Full Text] [Related]
3. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. Jatoi A; Hillman S; Stella P; Green E; Adjei A; Nair S; Perez E; Amin B; Schild SE; Castillo R; Jett JR; J Clin Oncol; 2005 Dec; 23(36):9113-9. PubMed ID: 16361618 [TBL] [Abstract][Full Text] [Related]
4. An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer. Hotta K; Ueoka H; Kiura K; Tabata M; Tanimoto M Lung Cancer; 2004 Oct; 46(1):61-76. PubMed ID: 15364134 [TBL] [Abstract][Full Text] [Related]
5. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors. Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N; Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010 [TBL] [Abstract][Full Text] [Related]
6. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy. Hotta K; Fujiwara Y; Matsuo K; Suzuki T; Kiura K; Tabata M; Takigawa N; Ueoka H; Tanimoto M Cancer; 2007 Mar; 109(5):939-48. PubMed ID: 17285602 [TBL] [Abstract][Full Text] [Related]
7. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD; J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640 [TBL] [Abstract][Full Text] [Related]
8. Lung cancer in the elderly. Gridelli C; Langer C; Maione P; Rossi A; Schild SE J Clin Oncol; 2007 May; 25(14):1898-907. PubMed ID: 17488989 [TBL] [Abstract][Full Text] [Related]
9. Management of the elderly patient with advanced non-small cell lung cancer. Cheong KA; Chrystal K; Harper PG Int J Clin Pract; 2006 Mar; 60(3):340-3. PubMed ID: 16494650 [TBL] [Abstract][Full Text] [Related]
10. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer. Früh M; Rolland E; Pignon JP; Seymour L; Ding K; Tribodet H; Winton T; Le Chevalier T; Scagliotti GV; Douillard JY; Spiro S; Shepherd FA J Clin Oncol; 2008 Jul; 26(21):3573-81. PubMed ID: 18640938 [TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Jiang J; Liang X; Zhou X; Huang R; Chu Z Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133 [TBL] [Abstract][Full Text] [Related]
12. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC). Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer. Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711 [TBL] [Abstract][Full Text] [Related]
14. Time and chemotherapy treatment trends in the treatment of elderly patients (age>or=70 years) with non-small cell lung cancer. O'Brien ME; Yau T; Coward J; Hughes S; Papadopoulos P; Popat S; Norton A; Ashley S Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):142-7. PubMed ID: 18093813 [TBL] [Abstract][Full Text] [Related]
15. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer. Murillo JR; Koeller J Oncologist; 2006; 11(10):1095-9. PubMed ID: 17110629 [TBL] [Abstract][Full Text] [Related]
17. Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer. Peschel C; Hartmann JT; Schmittel A; Bokemeyer C; Schneller F; Keilholz U; Buchheidt D; Millan S; Izquierdo MA; Hofheinz RD Lung Cancer; 2008 Jun; 60(3):374-80. PubMed ID: 18054408 [TBL] [Abstract][Full Text] [Related]
18. Present trends in the treatment of advanced non small-cell lung cancer. Parvez T; Allam AR; Iskandrani A; Khan MA J Coll Physicians Surg Pak; 2003 Aug; 13(8):483-90. PubMed ID: 12921691 [TBL] [Abstract][Full Text] [Related]
19. The role of maintenance chemotherapy in advanced nonsmall cell lung cancer. Jalal SI; Ademuyiwa FO; Hanna NH Curr Opin Oncol; 2009 Mar; 21(2):110-5. PubMed ID: 19532011 [TBL] [Abstract][Full Text] [Related]